Publications

Weirauch, U., Kreuz, M., Birkenbihl, C., Alb, M., Quaranta, M., Calzone, L., Orozco-Ruiz, S., Binder, S., Fischer, L., Clavreul, S., Maguri, M., Ferle, M., Rade, M., Azarias, G., Hydren, J. R., Jamarik, J., Schwarz, D., Sebestyen, Z., Kuball, J., Popp, G., … CERTAINTY Consortium (2025). Design specifications for biomedical virtual twins in engineered adoptive cellular immunotherapies. NPJ digital medicine, 8(1), 493. https://doi.org/10.1038/s41746-025-01809-6

Wiemers, T., Ferle, M., Ader, J., Sotikova, V., Fandrei, D., Grieb, N., Fischer, L., Born, P., Weidner, H., Wang, S. Y., Jentzsch, M., Franke, G. N., Herling, C., Metzeler, K., Herling, M., Heyn, S., Denecke, T., Reiche, K., Platzbecker, U., Vucinic, V., … Merz, M. (2025). Prognostic implications of splenomegaly in BCMA-directed CAR T-Cell therapy for relapsed myeloma. Transplantation and cellular therapy, S2666-6367(25)01289-8. Advance online publication. https://doi.org/10.1016/j.jtct.2025.07.003

Reiche, K., Weirauch, U., Kreuz. M., Fischer, L., Gras, L., Neumuth, T., Platzbecker, U., Köhl, U., Demlova, R., Kremer, A., Fröhlich, H., Franke, S., Merz, M., on behalf of the CERTAINTY consortium. (2025). Virtual twins for personalised CAR T-cell therapy in myeloma. The Lancet Haematology, 12(7), E490-E491. https://doi.org/10.1016/S2352-3026(25)00170-X

Born, P., Fandrei, D., Wang, S. Y., Perez-Fernandez, C., Fischer, L., Ussmann, J., Bach, E., Hoffmann, S., Metzeler, K. H., Herling, M., Herling, C., Jentzsch, M., Boldt, A., Seiffert, S., Baber, R., Weidner, H., Franke, G. N., Denecke, T., Sabri, O., Platzbecker, U., … Merz, M. (2025). Prognostic significance of PET/CT for CAR T cell therapy in relapsed/refractory multiple myeloma. HemaSphere, 9(6), e70159. https://doi.org/10.1002/hem3.70159

Merz, M., Gagelmann, N., Smaili, S., Flossdorf, S., Sauer, S., Scheid, C., von Tresckow, B., Wulf, G. G., Weisel, K. C., Blau, I., Engelhardt, M., Wäsch, R., Schub, N., Teipel, R., Hecker, J. S., Waldschmidt, J. M., Besemer, B., Baermann, B. N., Call, S., Hansmann, L., … Kröger, N. (2025). Remission conversion drives outcomes after CAR T-cell therapy for multiple myeloma: a registry analysis from the DRST. Blood, blood.2025028330. Advance online publication. https://doi.org/10.1182/blood.2025028330